Insider Activity QuantSignals AI Tracker 2025-11-07 🔍 INSIDER ACTIVITY DETECTED - FOLLOW THE SMART MONEY AI Analysis of Corporate Insider Buying Patterns ════════════════════════════════════════════════════════════════════════════════ 💰 INSIDER ACTIVITY SIGNALS Generated: November 07, 2025 at 12:37 AM ════════════════════════════════════════════════════════════════════════════════ 📊 5 Total Opportunities • ✅ 2 Ready to Trade • ⏸️ 3 Monitor ──────────────────────────────────────────────────────────────────────────────── ┌─ #1 ✅ NYSE:UNH • Score: 75/100 • ENTER NOW │ │ 📅 DTE: 90-180 days │ 🟢 Risk Level: Low Risk (3/10) │ │ 📰 Catalyst: 5 txns, 5 insiders, $31.6M total, 0 in 30d │ 📊 Setup: Large purchases: $31.6M total value - significant skin in game │ 🎯 Target: 10-20% upside in 3-6 months (moderate insider signal) │ 📈 Options: CALL options 3-6 months out for insider momentum │ │ 💡 Trade - Solid insider signal │ ⚠️ Risk: Insider buying is leading indicator, not guarantee - monitor fundamentals └─────────────────────────────────────────────────────────────────────────────── ┌─ #2 ✅ NYSE:LLY • Score: 65/100 • ENTER NOW │ │ 📅 DTE: 90-180 days │ 🟡 Risk Level: Medium Risk (4/10) │ │ 📰 Catalyst: 8 txns, 8 insiders, $4.5M total, 0 in 30d │ 📊 Setup: Insider accumulation pattern developing │ 🎯 Target: 10-20% upside in 3-6 months (moderate insider signal) │ 📈 Options: CALL options 3-6 months out for insider momentum │ │ 💡 Trade - Solid insider signal │ ⚠️ Risk: Insider buying is leading indicator, not guarantee - monitor fundamentals └─────────────────────────────────────────────────────────────────────────────── ┌─ #3 ⏸️ NASDAQ:TSLA • Score: 35/100 • WAIT │ │ 📅 DTE: 90-180 days │ 🟡 Risk Level: Medium Risk (6/10) │ │ 📰 Catalyst: 1 txns, 1 insiders, $1000.0M total, 0 in 30d │ 📊 Setup: Large purchases: $1000.0M total value - significant skin in game │ 🎯 Target: Image 5-15% upside in 3-6 months (developing insider signal) │ 📈 Options: CALL options 3-6 months out for insider momentum │ │ 💡 Watch - Developing insider interest │ ⚠️ Risk: Insider buying is leading indicator, not guarantee - monitor fundamentals └─────────────────────────────────────────────────────────────────────────────── ┌─ #4 ⏸️ NASDAQ:OPEN • Score: 35/100 • WAIT │ │ 📅 DTE: 90-180 days │ 🟡 Risk Level: Medium Risk (6/10) │ │ 📰 Catalyst: 2 txns, 2 insiders, $2.8M total, 0 in 30d │ 📊 Setup: Insider accumulation pattern developing │ 🎯 Target: 5-15% upside in 3-6 months (developing insider signal) │ 📈 Options: CALL options 3-6 months out for insider momentum │ │ 💡 Watch - Developing insider interest │ ⚠️ Risk: Insider buying is leading indicator, not guarantee - monitor fundamentals └─────────────────────────────────────────────────────────────────────────────── ┌─ #5 ⏸️ NASDAQ:AVGO • Score: 25/100 • WAIT │ │ 📅 DTE: 90-180 days │ 🔴 Risk Level: High Risk (7/10) │ │ 📰 Catalyst: 1 txns, 1 insiders, $1.2M total, 0 in 30d │ 📊 Setup: Insider accumulation pattern developing │ 🎯 Target: 5-15% upside in 3-6 months (developing insider signal) │ 📈 Options: CALL options 3-6 months out for insider momentum │ │ 💡 Watch - Developing insider interest │ ⚠️ Risk: Insider buying is leading indicator, not guarantee - monitor fundamentals └─────────────────────────────────────────────────────────────────────────────── ──────────────────────────────────────────────────────────────────────────────── 📖 QUICK GUIDE: ✅ ENTER NOW → High probability setup, optimal timing, low-medium risk ⏸️ WAIT → Monitor for better entry or catalyst resolution 🟢 Low Risk → Heat 1-3 (stable, far from catalysts) 🟡 Med Risk → Heat 4-6 (moderate volatility) 🔴 High Risk → Heat 7-10 (near catalysts, high volatility) 💎 Position Sizing: 2-5% per trade • Max 2-3 concurrent positions 🎯 Exit Strategy: Take profit at 50% max gain or stop at 2x loss ════════════════════════════════════ ════════════════════════════════════════════

1) Price did touch MA 50 on daily. 2) Maybe Head and Shoulders pattern. 3) Wedge.

Price is Entering a Demand Zone. Entry 345.30 Stop 340.30 Target 363.03

NYSE:UNH UnitedHealth Group Incorporated (UNH) is showing all the technical and fundamental signs of a major bullish reversal. After a steep decline, the weekly chart has now triggered a powerful signal: the 9-period Simple Moving Average (SMA) has crossed above the 20-period SMA, confirming short-term momentum and marking the start of a new uptrend. This crossover, highlighted in the chart, historically precedes large moves higher, especially when supported by rising trading volume and positive company developments. What’s even better, UNH just released robust earnings that beat market expectations, demonstrating the company's resilience and growth potential even in challenging environments. Q3 revenue reached $113.2 billion, a 12% year-over-year increase driven by double-digit growth in both UnitedHealthcare and Optum segment Technically, there’s a clear path towards the near-term resistance around $436, and a break above this level could open the door for a run back to previous highs near $487. With a recovery in fundamentals and a high-probability technical setup, UNH now has the potential to deliver gains of over 40% from current prices—backed by both chart dynamics and a strong earnings trend.

The share price of UnitedHealth Group Incorporated (NYSE: NYSE:UNH ) is up 4% in Tuesday's premarket session as the company reports earnings results 28 October, 2025 before the bell. UnitedHealth Group raised its 2025 earnings outlook to reflect net earnings of at least $14.90 per share and adjusted net earnings of at least $16.25 per share. Third Quarter 2025 Key Performance Metrics Consolidated revenues of $113.2 billion, up 12% year-over-year. Earnings from operations were $4.3 billion; net margin of 2.1%. Adjusted EPS of $2.92; GAAP EPS of $2.59. Medical care ratio (MCR) of 89.9% was in line with expectations outlined in the second quarter 2025. Operating cost ratio of 13.5% reflecting investments to support future growth. UnitedHealthcare revenues grew 16% year-over-year to $87.1 billion, driven by growth in Medicare & Retirement and Community & State; UnitedHealthcare served 50.1 million consumers domestically, up 795,000 year-over-year. Optum revenues grew 8% year-over-year to $69.2 billion, driven by growth in Optum Rx. September 30, 2025, debt-to-capital ratio of 44.1% unchanged from the second quarter 2025 and inclusive of the impact of closing the Amedisys transaction on August 14, 2025. Technical Outlook With the RSI at 58, NYSE:UNH is poised to break the $381 resistant zone paving the way for a much more greater strides. Similarly, on a more bullish tone, the stock's moving averages have cross paths indicating possible resurgence of a golden cross.

Strong Trend Line being retested I expect as bounce off this trend line as price history extends back quite a long time. Good dip buy long option. Weekly chart.

- NYSE:UNH offers best risk to reward for 2026 - Increase in premium is going to kick off starting 2026 - All these revisions by analyst would be easy to beat. - NYSE:UNH has been eating up the shares when it was beaten down should also boost eps - Technically, breakout -> consolidate -> breakout is more sustainable. Good luck everyone!

- NYSE:UNH has nothing to do with China-US trade war because all of its business is in US. - Companies which will get hurt by China - US tensions would be MNCs ( multi national companies) , Chips related companies, Retail like clothing, beauty products and some healthcare which get raw materials from the china for drug. - Insurance related companies should do well amidst this macro development. - NYSE:UNH selling on china related trade war is so stupid and I believe it's algorithmic selling but once institutional investors and fund managers come back to senses. - They should consider parking money in NYSE:UNH for safe compounding amidst this new macro shenanigan. - NYSE:UNH is still undervalued, defensive & doesn't have any exposure to US-china trade wars. - NYSE:UNH is increasing rates for premium starting 2026 that's one more big tailwind.

Enter: NYSE:UNH OCT 31 2025 $375 CALLS Buy in Price: $15.75 - $15.90 Take Profit: $32.60 Stop Bleeding: $13.86 ROI Potential: 107% Exit Within: 255 Minutes

This market has gone completely crazy! Either we go from overselling to overbuying, or we witness a total bubble! When is this circus going to stop? Soon, half on SPY will have P/E ratio of 100 and everyone will find that normal!